ABX-002 is under clinical development by Autobahn Therapeutics and currently in Phase II for Major Depressive Disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback